newsfilter
← Latest News
GlobeNewswire·

Heat Biologics Announces Addition of Former US Senator Mark Pryor to Biothreat Advisory Board

DURHAM, N.C., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, announces the addition of Mark Pryor,